| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |